| (210) | Number of the EPO application | 16816363 |
| (220) | Filing date of the EPO application | 2016.12.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 37/2020, 2020.09.09 |
| (110) | EPO patent number | 3390395 |
| (11) | Number of the document | MD 3390395 T2 |
| (21) | Number of the application | e 2018 1001 |
| (71) | Name(s) of applicant(s), code of the country | Loxo Oncology, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | GUISOT Nicolas, GB; |
| (73) | Name(s) of owner(s), code of the country | LOXO Oncology Inc., US; |
| (54) | Title of the invention | Ccompounds useful as kinase inhibitors |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 405/14 (2006.01.01); A61K 31/415 (2006.01.01); A61K 31/4155 (2006.01.01); C07D 231/14 (2006.01.01); C07D 401/04 (2006.01.01); C07D 401/06 (2006.01.01); C07D 403/04 (2006.01.01); C07D 405/04 (2006.01.01); C07D 405/06 (2006.01.01); C07D 405/08 (2006.01.01); C07D 413/06 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.11.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.02.28 |
| (30) | Priority | 201522245, 2015.12.16, GB; 201613945, 2016.08.15, GB |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/GB2016/053968, 2016.12.16 |
| (87) | International publication | WO 2017/103611, 2017.06.22 |